Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges.
暂无分享,去创建一个
[1] J. Jokerst,et al. Gold Nanorod-Melanin Hybrids for Enhanced and Prolonged Photoacoustic Imaging in the Near-Infrared-II Window. , 2021, ACS applied materials & interfaces.
[2] Gan Lin,et al. Gain an advantage from both sides: Smart size-shrinkable drug delivery nanosystems for high accumulation and deep penetration , 2021 .
[3] Joseph J. Richardson,et al. Polyphenol-Mediated Assembly for Particle Engineering. , 2020, Accounts of chemical research.
[4] Qinghua Wu,et al. Light-assisted hierarchical intratumoral penetration and programmed antitumor therapy based on tumor microenvironment (TME)-amendatory and self-adaptive polymeric nanoclusters. , 2020, Biomaterials.
[5] Gang Zheng,et al. Guidelines for the experimental design of pharmacokinetic studies with nanomaterials in preclinical animal models. , 2020, Journal of controlled release : official journal of the Controlled Release Society.
[6] P. Mi. Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics , 2020, Theranostics.
[7] S. Wilhelm,et al. The entry of nanoparticles into solid tumours , 2020, Nature Materials.
[8] Xiaoyuan Chen,et al. Metal-organic frameworks nanoswitch: Toward photo-controllable endo/lysosomal rupture and release for enhanced cancer RNA interference , 2020, Nano Research.
[9] Batakrishna Jana,et al. Cancer‐Targeted Nanomedicine: Overcoming the Barrier of the Protein Corona , 2020, Advanced Therapeutics.
[10] Xuexiang Han,et al. Emerging nanomedicines for anti-stromal therapy against desmoplastic tumors. , 2019, Biomaterials.
[11] G. Zheng,et al. Nanomedicines Lost in Translation. , 2019, ACS nano.
[12] Fabian Kiessling,et al. Smart cancer nanomedicine , 2019, Nature Nanotechnology.
[13] Xiaodong Zhang,et al. Construction of Dually Responsive Nanotransformers with Nanosphere-Nanofiber-Nanosphere Transition for Overcoming the Size Paradox of Anticancer Nanodrugs. , 2019, ACS nano.
[14] T. Dvir,et al. Collagenase Nanoparticles Enhance the Penetration of Drugs Into Pancreatic Tumors. , 2019, ACS nano.
[15] K. Yarema,et al. Exploiting metabolic glycoengineering to advance healthcare , 2019, Nature Reviews Chemistry.
[16] S. Torp,et al. Effect of Ultrasound on the Vasculature and Extravasation of Nanoscale Particles Imaged in Real Time. , 2019, Ultrasound in medicine & biology.
[17] Z. Qian,et al. Physical-, chemical-, and biological-responsive nanomedicine for cancer therapy. , 2019, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[18] Min Liu,et al. Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures. , 2019, Accounts of chemical research.
[19] K. Kataoka,et al. Ligand‐Installed Nanocarriers toward Precision Therapy , 2019, Advanced materials.
[20] Zhihua Gan,et al. Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy , 2019, Nature Nanotechnology.
[21] Xianming Deng,et al. Environmentally responsive dual-targeting nanotheranostics for overcoming cancer multidrug resistance. , 2019, Science bulletin.
[22] F. Caruso,et al. Selective Metal-Phenolic Assembly from Complex Multicomponent Mixtures. , 2019, ACS applied materials & interfaces.
[23] S. Wilhelm,et al. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. , 2019, Advanced drug delivery reviews.
[24] Peipei Xu,et al. Overcoming Hypoxia by Multistage Nanoparticle Delivery System to Inhibit Mitochondrial Respiration for Photodynamic Therapy , 2019, Advanced Functional Materials.
[25] Betty Y. S. Kim,et al. Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery , 2019, Advanced science.
[26] Wei Chen,et al. Metal–Organic Framework‐Based Stimuli‐Responsive Systems for Drug Delivery , 2018, Advanced science.
[27] Chunying Chen,et al. The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine , 2018, Advanced materials.
[28] Xiaoyuan Chen,et al. Tumor Microenvironment-Responsive Ultrasmall Nanodrug Generators with Enhanced Tumor Delivery and Penetration. , 2018, Journal of the American Chemical Society.
[29] Jin-Zhi Du,et al. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine. , 2018, Accounts of chemical research.
[30] Edmund J. Crampin,et al. Minimum information reporting in bio–nano experimental literature , 2018, Nature Nanotechnology.
[31] Rui Tian,et al. Hierarchical Tumor Microenvironment‐Responsive Nanomedicine for Programmed Delivery of Chemotherapeutics , 2018, Advanced materials.
[32] Ding Ding,et al. Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors. , 2018, ACS nano.
[33] X. Chu,et al. Biomineralized Metal-Organic Framework Nanoparticles Enable Intracellular Delivery and Endo-Lysosomal Release of Native Active Proteins. , 2018, Journal of the American Chemical Society.
[34] Xiaoyuan Chen,et al. Stimuli-Responsive NO Release for On-Demand Gas-Sensitized Synergistic Cancer Therapy. , 2018, Angewandte Chemie.
[35] R. Weichselbaum,et al. Nanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications , 2018, Advanced materials.
[36] K. Landfester,et al. Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona , 2018, Nature Nanotechnology.
[37] Dan Peer,et al. Progress and challenges towards targeted delivery of cancer therapeutics , 2018, Nature Communications.
[38] M. Gottesman,et al. Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.
[39] Zhen Gu,et al. Advances in transformable drug delivery systems. , 2018, Biomaterials.
[40] Weihong Zhu,et al. Multifunctional Shell–Core Nanoparticles for Treatment of Multidrug Resistance Hepatocellular Carcinoma , 2018 .
[41] Huile Gao,et al. Influence of ligands property and particle size of gold nanoparticles on the protein adsorption and corresponding targeting ability. , 2018, International journal of pharmaceutics.
[42] Paul Kumar Upputuri,et al. Compact Plasmonic Blackbody for Cancer Theranosis in the Near-Infrared II Window. , 2018, ACS nano.
[43] Gang Zheng,et al. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics. , 2018, Biomaterials.
[44] Fajr A. Aleisa,et al. Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework. , 2018, Journal of the American Chemical Society.
[45] Qin Chen,et al. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics. , 2018, Trends in pharmacological sciences.
[46] Z. Tian,et al. pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells. , 2017, Biomaterials.
[47] Jean-Christophe Leroux,et al. Editorial: Drug Delivery: Too Much Complexity, Not Enough Reproducibility? , 2017, Angewandte Chemie.
[48] Kwangmeyung Kim,et al. Deep tissue penetration of nanoparticles using pulsed-high intensity focused ultrasound , 2017, Nano Convergence.
[49] Ick Chan Kwon,et al. Extracellular matrix remodeling in vivo for enhancing tumor‐targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[50] Jong-Min Lim,et al. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics , 2017, Nature Communications.
[51] Lanlan Liu,et al. Cancer Cell Membrane‐Biomimetic Oxygen Nanocarrier for Breaking Hypoxia‐Induced Chemoresistance , 2017 .
[52] T. Ji,et al. Nanoparticle-mediated local depletion of tumour-associated platelets disrupts vascular barriers and augments drug accumulation in tumours , 2017, Nature Biomedical Engineering.
[53] Jianjun Cheng,et al. Sequentially Responsive Shell‐Stacked Nanoparticles for Deep Penetration into Solid Tumors , 2017, Advanced materials.
[54] Xiaoyuan Chen,et al. Tumor Microenvironment‐Triggered Supramolecular System as an In Situ Nanotheranostic Generator for Cancer Phototherapy , 2017, Advanced materials.
[55] Miles A. Miller,et al. Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts , 2017, Science Translational Medicine.
[56] Leaf Huang,et al. Quercetin Remodels the Tumor Microenvironment To Improve the Permeation, Retention, and Antitumor Effects of Nanoparticles. , 2017, ACS nano.
[57] Yajun Wang,et al. Near‐Infrared Laser‐Triggered Nitric Oxide Nanogenerators for the Reversal of Multidrug Resistance in Cancer , 2017 .
[58] Youqing Shen,et al. Rational Design of Cancer Nanomedicine: Nanoproperty Integration and Synchronization , 2017, Advanced materials.
[59] Xuesi Chen,et al. Selective in vivo metabolic cell-labeling-mediated cancer targeting. , 2017, Nature chemical biology.
[60] Naser Karimi,et al. Application of Various Types of Liposomes in Drug Delivery Systems , 2017, Advanced pharmaceutical bulletin.
[61] Morteza Mahmoudi,et al. Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. , 2017, Trends in biotechnology.
[62] Wen Jiang,et al. Breaking Down the Barriers to Precision Cancer Nanomedicine. , 2017, Trends in biotechnology.
[63] Dan Peer,et al. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. , 2017, ACS nano.
[64] P. Kantoff,et al. Cancer nanomedicine: progress, challenges and opportunities , 2016, Nature Reviews Cancer.
[65] Liangzhu Feng,et al. Liposomes co-loaded with metformin and chlorin e6 modulate tumor hypoxia during enhanced photodynamic therapy , 2017, Nano Research.
[66] Huile Gao,et al. Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation. , 2016, ACS nano.
[67] Yingying Xu,et al. Gd‐Hybridized Plasmonic Au‐Nanocomposites Enhanced Tumor‐Interior Drug Permeability in Multimodal Imaging‐Guided Therapy , 2016, Advanced materials.
[68] Kai Yang,et al. Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies. , 2016, Nano letters.
[69] Xiaoyuan Chen,et al. Hierarchical Targeting Strategy for Enhanced Tumor Tissue Accumulation/Retention and Cellular Internalization , 2016, Advanced materials.
[70] M. Mahmoudi,et al. Bypassing Protein Corona Issue on Active Targeting: Zwitterionic Coatings Dictate Specific Interactions of Targeting Moieties and Cell Receptors. , 2016, ACS applied materials & interfaces.
[71] Hengte Ke,et al. Rational Design of Multi-Stimuli-Responsive Nanoparticles for Precise Cancer Therapy. , 2016, ACS nano.
[72] F. Kiessling,et al. Sonoporation enhances liposome accumulation and penetration in tumors with low EPR. , 2016, Journal of controlled release : official journal of the Controlled Release Society.
[73] Michael R Hamblin,et al. Albumin nanostructures as advanced drug delivery systems , 2016, Expert opinion on drug delivery.
[74] Zhen Gu,et al. Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery , 2016 .
[75] P. Mi,et al. Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics , 2016, Advanced science.
[76] A. J. Tavares,et al. Analysis of nanoparticle delivery to tumours , 2016 .
[77] Hao Cheng,et al. Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy. , 2016, Nano letters.
[78] Katharina Landfester,et al. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.
[79] Kam W. Leong,et al. Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines , 2016 .
[80] Jun Wang,et al. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy , 2016, Proceedings of the National Academy of Sciences.
[81] Mingyuan Gao,et al. In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics , 2016, Nature Communications.
[82] Tianyue Jiang,et al. Tumor Microenvironment-Mediated Construction and Deconstruction of Extracellular Drug-Delivery Depots. , 2016, Nano letters.
[83] Yuliang Zhao,et al. Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer‐Associated Fibroblast Activation , 2015, Angewandte Chemie.
[84] Leaf Huang,et al. Stromal barriers and strategies for the delivery of nanomedicine to desmoplastic tumors. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[85] Song Shen,et al. Tumor Acidity-Sensitive Polymeric Vector for Active Targeted siRNA Delivery. , 2015, Journal of the American Chemical Society.
[86] Kaikai Wang,et al. Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy , 2015, Nature Communications.
[87] Mauro Ferrari,et al. Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.
[88] Raimo Hartmann,et al. Surface Functionalization of Nanoparticles with Polyethylene Glycol: Effects on Protein Adsorption and Cellular Uptake. , 2015, ACS nano.
[89] M. Eblan,et al. Clinical Translation of Nanomedicine. , 2015, Chemical reviews.
[90] Kinam Park,et al. Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities. , 2015, Chemical engineering science.
[91] Jörg Huwyler,et al. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[92] H. Ai,et al. Delivery of siRNA by MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells. , 2014, Biomaterials.
[93] Leone Spiccia,et al. Zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system. , 2014, Small.
[94] Bo Yan,et al. Fabrication of Corona-Free Nanoparticles with Tunable Hydrophobicity , 2014, ACS nano.
[95] Xiaomin Wang,et al. Smart pH- and reduction-dual-responsive folate-PEG-coated polymeric lipid vesicles for tumor-triggered targeted drug delivery. , 2014, Nanoscale.
[96] R. Leapman,et al. Targeted Therapeutic Nanotubes Influence the Viscoelasticity of Cancer Cells to Overcome Drug Resistance , 2014, ACS nano.
[97] R. Dacosta,et al. Multifunctional albumin-MnO₂ nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response. , 2014, ACS nano.
[98] Zhen Gu,et al. Gel–Liposome‐Mediated Co‐Delivery of Anticancer Membrane‐Associated Proteins and Small‐Molecule Drugs for Enhanced Therapeutic Efficacy , 2014 .
[99] Giulio Caracciolo,et al. Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. , 2014, Nanoscale.
[100] Y. Bae,et al. Biodegradable cationic nanoparticles loaded with an anticancer drug for deep penetration of heterogeneous tumours. , 2013, Biomaterials.
[101] Dieter Haemmerich,et al. Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[102] Philip M. Kelly,et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.
[103] K. Greish,et al. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link? , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[104] Kwangmeyung Kim,et al. Bioorthogonal copper-free click chemistry in vivo for tumor-targeted delivery of nanoparticles. , 2012, Angewandte Chemie.
[105] Lin Zhu,et al. Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting. , 2012, ACS nano.
[106] R. Jain,et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner , 2012, Nature nanotechnology.
[107] M. Uesaka,et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.
[108] R. Gillies,et al. Drug resistance and cellular adaptation to tumor acidic pH microenvironment. , 2011, Molecular pharmaceutics.
[109] Ajit S Narang,et al. Role of tumor vascular architecture in drug delivery. , 2011, Advanced drug delivery reviews.
[110] Jesse V Jokerst,et al. Nanoparticle PEGylation for imaging and therapy. , 2011, Nanomedicine.
[111] Neetu Singh,et al. Nanoparticles that communicate in vivo to amplify tumour targeting. , 2011, Nature materials.
[112] Gert Storm,et al. Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[113] Iseult Lynch,et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.
[114] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[115] P. Choyke,et al. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. , 2008, Nanomedicine.
[116] Milan Makale,et al. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis , 2008, Proceedings of the National Academy of Sciences.
[117] Milan Makale,et al. Cellular mechanobiology and cancer metastasis. , 2007, Birth defects research. Part C, Embryo today : reviews.
[118] P. Vaupel,et al. Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.
[119] Kristian Pietras,et al. High interstitial fluid pressure — an obstacle in cancer therapy , 2004, Nature Reviews Cancer.
[120] A. Santoro,et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.